# Jamie Justice and the Longevity Revolution’s Most Unpopular Truth There is a strange tension at the heart of the modern longevity movement. On one side are billionaires, biotech founders,…
New research from 2025 and 2026 confirms that zone 2 training, the low intensity aerobic exercise most people skip, is the single most effective way to build mitochondrial density, improve…
A convergence of 2026 studies in Nature Medicine and Nature Aging is transforming Alzheimer’s detection. The p-tau217 blood test clock predicts symptom onset within three to four years, a finger…
A new generation of AI systems does not just assist scientists; it organizes itself into research teams, designs experiments, debates hypotheses, and identifies drug candidates at speeds no human laboratory…
🔬 Aging Redefined as Systems Failure: Researchers in Berlin are shifting the aging conversation toward preserving biological coordination across systems, not fixing a single defect. 🤖 AI Drug Discovery Reaches Scale: Over 173 AI-discovered drug programs are now in clinical trials, and a new free platform targeting global diseases launched this week. 😴 Sleep as a Disease Predictor: Stanford's SleepFM AI model predicts 130+ conditions from one night of sleep data, positioning sleep as a critical longevity biomarker. 🦠 Gut Microbiome Controls Immunity Directly: Common gut microbes inject proteins into immune cells, and a single bacterial metabolite doubled lung cancer immunotherapy response in mice. ❤️ Long-Term Heart-Aging Study Begins: UTMB's decade-long Galveston Heart Study will track thousands of participants to uncover how cardiovascular and brain health intersect with aging.
New research from three landmark 2026 studies reveals that continuous glucose monitors can detect hidden metabolic dysfunction, predict cardiovascular risk, and personalize nutrition in people without diabetes. The science is…
A foundation model company just paid $400 million in stock for a team of fewer than 10 people. The implications for drug discovery, precision medicine, and the entire healthcare AI…
A convergence of cfDNA methylation analysis, multi-omics integration, and artificial intelligence is transforming cancer screening. From the PATHFINDER 2 trial showing a seven-fold increase in cancer detection to the PROMISE…
A landmark Cell Reports Medicine study analyzed the genome, epigenome, microbiome, and metabolome of Maria Branyas Morera, the world’s oldest verified person. The findings reveal that extreme longevity results from…
ARPA-H’s $144 million PROSPR program is testing rapamycin, semaglutide, and dapagliflozin in 726 healthy older adults, funding a first-in-humans trial of a retrotransposon-silencing HIV drug, and building a validated biological…
Zach RobertsSign up for personalized wellness coaching and the Daily Discovery Newsletter.